FGL vs N-Acetyl Selank Amidate

Evidence-based comparison. Updated 2026.

FGL and N-Acetyl Selank Amidate target different aspects of brain health. FGL is an NCAM mimetic focused on synaptic plasticity, memory formation, and neuroprotection, making it the stronger candidate for cognitive enhancement and neurological repair. N-Acetyl Selank Amidate is better suited for anxiety reduction, stress adaptation, and mood stabilization with a nootropic secondary benefit. Choose FGL for structural neural support; choose N-Acetyl Selank Amidate for functional cognitive and emotional regulation.

Side by side

	FGL	N-Acetyl Selank Amidate
Evidence	CEvidenceGrade CMainly animal or in-vitro studies, with limited human data	BEvidenceGrade BSmaller human trials or observational studies, or approved in 30+ countries
Regulatory	Research onlyResearch onlyNo regulatory approval in any major jurisdiction. For research use only	CompoundableCompoundableLegal to compound in the US, or approved in other jurisdictions or historically
Benefits	Enhances memory formation and retention Promotes neural plasticity and synaptic growth Supports neuroprotection against excitotoxicity Improves cognitive function and learning capacity Reduces neuroinflammation in brain tissue	Reduces anxiety and promotes relaxation Enhances cognitive function and mental clarity Improves mood and emotional resilience Supports stress adaptation and coping Promotes better sleep quality
Dosage	1-5 mg, 1x daily	200-400 mcg, 1-2x daily
Route	Subcutaneous	Subcutaneous
Category	Cognitive Enhancement	Cognitive Enhancement

Full research page

FGL

Full research page

N-Acetyl Selank Amidate

Which should you choose

FGL works at the level of synaptic architecture by mimicking NCAM signaling and activating fibroblast growth factor receptors, promoting long-term potentiation and neuronal survival. N-Acetyl Selank Amidate operates through monoamine and GABAergic neurotransmitter modulation, producing anxiolytic and nootropic effects without directly influencing synaptic growth pathways.

Choose FGL when

Research goal involves enhancing memory consolidation, long-term potentiation, or synaptic plasticity at a structural level.
Focus is on neuroprotection against excitotoxic or neuroinflammatory damage rather than mood or stress modulation.
The primary interest is in NCAM-mediated neural repair or cognitive performance improvements rooted in synaptic remodeling.

Choose N-Acetyl Selank Amidate when

Primary concern is anxiety reduction, emotional resilience, or stress adaptation with secondary cognitive benefits.
Interest in a peptide with a stronger evidence base (Grade B) and compoundable regulatory status for broader accessibility.
Goals include improving sleep quality, focus, and mental clarity through neurotransmitter modulation rather than synaptic structural changes.

Stacking FGL with N-Acetyl Selank Amidate is not a widely documented practice in the research literature, but the mechanisms are largely complementary, with FGL addressing synaptic plasticity and N-Acetyl Selank Amidate targeting neurotransmitter tone and anxiolysis.

Questions people ask

Do FGL and N-Acetyl Selank Amidate overlap in their cognitive enhancement effects, and how do those effects differ?

Both peptides have been associated with cognitive improvements in research settings, but through distinct pathways. FGL enhances cognition by promoting synaptic plasticity and long-term potentiation via FGFR activation, which supports the structural basis of memory. N-Acetyl Selank Amidate improves cognitive clarity and focus primarily through monoamine neurotransmitter modulation, which influences mental state and processing speed rather than synaptic architecture. The result is that FGL targets memory formation more directly, while N-Acetyl Selank Amidate targets the functional cognitive environment.

Which peptide is likely to show effects faster, FGL or N-Acetyl Selank Amidate?

N-Acetyl Selank Amidate is expected to produce more rapid observable effects given its action on monoamine and GABAergic systems, which influence mood and anxiety on a shorter timescale. FGL works through receptor-mediated synaptic remodeling and neuroplasticity processes that are inherently slower, as structural changes in neural connectivity develop over days to weeks. For researchers seeking near-term anxiolytic or nootropic effects, N-Acetyl Selank Amidate is the more immediate option.

Is there a rationale for stacking FGL with N-Acetyl Selank Amidate in a research protocol?

A theoretical rationale exists because the two peptides address different levels of brain function without obvious mechanistic interference. FGL could support the structural foundation of learning by reinforcing synaptic connections, while N-Acetyl Selank Amidate could reduce stress-related cognitive interference through anxiolysis and neurotransmitter stabilization. However, no peer-reviewed studies have specifically examined this combination, so any stacking protocol remains exploratory and should be approached with appropriate caution in a research context.

How does the evidence quality and regulatory status of FGL versus N-Acetyl Selank Amidate affect how researchers should approach each peptide?

N-Acetyl Selank Amidate holds a Grade B evidence rating and compoundable regulatory status, meaning it has a broader and more consistent body of research supporting its effects and is accessible through compounding frameworks in some jurisdictions. FGL carries a Grade C evidence rating and is classified as research-only, indicating a more limited and preliminary evidence base. Researchers selecting between the two should weigh this difference in evidence quality and factor in the regulatory constraints of their specific research environment before incorporating either compound into a protocol.

Not sure which fits your research goals?

Use the goal finder

Answer three questions and get a peptide recommendation ranked by evidence grade.

Find my peptide